Rituximab in non-haematological disorders of adults and its mode of action

British Journal of Haematology

Volumn 146, Issue 3, 2009, Pages 233-246

  McDonald, Vickie ^a   Leandro, Maria ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Dermatology; Endocrine; Neurology; Renal; Rheumatology; Rituximab

Indexed keywords

CD20 ANTIGEN; CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN; METHOTREXATE; RITUXIMAB; STEROID;

ACUTE GRAFT REJECTION; ANCA ASSOCIATED VASCULITIS; ARTERY THROMBOSIS; B LYMPHOCYTE; BLOOD GROUP ABO INCOMPATIBILITY; BRADYCARDIA; CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY; CRYOGLOBULINEMIA; DERMATOMYOSITIS; DRUG HALF LIFE; DRUG MECHANISM; DRUG MEGADOSE; GRAVES DISEASE; HEPATITIS C; HUMAN; IMMUNOGLOBULIN DEFICIENCY; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; LYMPHOMA; MEMBRANOUS GLOMERULONEPHRITIS; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; MULTIPLE SCLEROSIS; MYASTHENIA GRAVIS; MYELOOPTIC NEUROPATHY; PARANEOPLASTIC SYNDROME; PEMPHIGUS; PERIPHERAL NEUROPATHY; POLYMYOSITIS; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; RETINA ARTERY THROMBOSIS; REVIEW; RHEUMATOID ARTHRITIS; SERUM SICKNESS; SINGLE DRUG DOSE; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE;

ADULT; ANTIBODIES, MONOCLONAL; CARDIOVASCULAR DISEASES; CONNECTIVE TISSUE DISEASES; ENDOCRINE SYSTEM DISEASES; HUMANS; KIDNEY DISEASES; NERVOUS SYSTEM DISEASES; PARANEOPLASTIC SYNDROMES; SKIN DISEASES; TRANSPLANTATION;

EID: 67650446931     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2009.07718.x     Document Type: Review

References (141)

1. Ahmed, A.R., Spigelman, Z., Cavacini, L.A. Posner, M.R. (2006) Treatment of pemphigus vulgaris with rituximab and intravenous immune globulin. The New England Journal of Medicine, 355, 1772 1779. (Pubitemid 44631360)
2. Albert, D., Dunham, J., Khan, S., Stansberry, J., Kolasinski, S., Tsai, D., Pullman-Mooar, S., Barnack, F., Striebich, C., Looney, R.J., Prak, E.T., Kimberly, R., Zhang, Y. Eisenberg, R. (2008) Variability in the biological response to anti-CD20 B cell depletion in systemic lupus erythaematosus. Annals of the Rheumatic Diseases, 67, 1724 1731.
3. Almuti, K., Haythe, J., Dwyer, E., Itescu, S., Burke, E., Green, P., Marboe, C. Mancini, D. (2007) The changing pattern of humoral rejection in cardiac transplant recipients. Transplantation, 84, 498 503. (Pubitemid 47312161)
4. Anolik, J.H., Campbell, D., Felgar, R.E., Young, F., Sanz, I., Rosenblatt, J. Looney, R.J. (2003) The relationship of FcgammaRIIIa genotype to degree of B cell depletion by rituximab in the treatment of systemic lupus erythematosus. Arthritis and Rheumatism, 48, 455 459. (Pubitemid 36278014)
5. Aranda, Jr., J.M., Scornik, J.C., Normann, S.J., Lottenberg, R., Schofield, R.S., Pauly, D.F., Miles, M., Hill, J.A., Sleasman, J.W. Skoda-Smith, S. (2002) Anti-CD20 monoclonal antibody (rituximab) therapy for acute cardiac humoral rejection: a case report. Transplantation, 73, 907 910. (Pubitemid 34252353)
6. Aries, P.M., Hellmich, B., Voswinkel, J., Both, M., Nolle, B., Holl-Ulrich, K., Lamprecht, P. Gross, W.L. (2006) Lack of efficacy of rituximab in Wegener's granulomatosis with refractory granulomatous manifestations. Annals of the Rheumatic Diseases, 65, 853 858.
7. Bagnasco, S.M., Tsai, W., Rahman, M.H., Kraus, E.S., Barisoni, L., Vega, R., Racusen, L.C., Haas, M., Mohammed, B.S., Zachary, A.A. Montgomery, R.A. (2007) CD20-positive infiltrates in renal allograft biopsies with acute cellular rejection are not associated with worse graft survival. American Journal of Transplantation, 7, 1968 1973. (Pubitemid 47037995)
8. Bar-Or, A., Calabresi, P.A., Arnold, D., Markowitz, C., Shafer, S., Kasper, L.H., Waubant, E., Gazda, S., Fox, R.J., Panzara, M., Sarkar, N., Agarwal, S. Smith, C.H. (2008) Rituximab in relapsing-remitting multiple sclerosis: a 72-week, open-label, phase I trial. Annals of Neurology, 63, 395 400.
9. Becker, Y.T., Becker, B.N., Pirsch, J.D. Sollinger, H.W. (2004) Rituximab as treatment for refractory kidney transplant rejection. American Journal of Transplantation, 4, 996 1001. (Pubitemid 38745599)
10. Benedetti, L., Briani, C., Franciotta, D., Carpo, M., Padua, L., Zara, G., Zambello, R., Sormani, M.P., Mancardi, G.L., Nobile-Orazio, E. Schenone, A. (2008a) Long-term effect of rituximab in anti-mag polyneuropathy. Neurology, 71, 1742 1744.
11. Benedetti, L., Franciotta, D., Beronio, A., Cadenotti, L., Gobbi, M., Mancardi, G.L., Schenone, A. Tartaglione, A. (2008b) Rituximab efficacy in CIDP associated with idiopathic thrombocytopenic purpura. Muscle and Nerve, 38, 1076 1077.
12. Berinstein, N.L., Grillo-Lopez, A.J., White, C.A., ce-Bruckler, I., Maloney, D., Czuczman, M., Green, D., Rosenberg, J., McLaughlin, P. Shen, D. (1998) Association of serum Rituximab (IDEC-C2B8) concentration and anti-tumor response in the treatment of recurrent low-grade or follicular non-Hodgkin's lymphoma. Annals of Oncology, 9, 995 1001. (Pubitemid 28496709)
13. Bierl, C., Miller, B., Prak, E.L., Gasiewski, A., Kearns, J., Tsai, D., Jessup, M. Kamoun, M. (2006) Antibody-mediated rejection in heart transplant recipients: potential efficacy of B-cell depletion and antibody removal. Clinical Transplants, 2006, 489 496.
14. Bonara, P., Vannucchi, G., Campi, I., Rossi, S., Cantoni, F., Frugoni, C., Sbrozzi, F., Guastella, C., Avignone, S., Beck-Peccoz, P. Salvi, M. (2008) Rituximab induces distinct intraorbital and intrathyroidal effects in one patient satisfactorily treated for graves' ophthalmopathy. Clinical Reviews in Allergy & Immunology, 34, 118 123.
15. Braun, A., Neumann, T., Oelzner, P., Hein, G., Grone, H.J., Ziemer, M. Wolf, G. (2008) Cryoglobulinaemia type III with severe neuropathy and immune complex glomerulonephritis: remission after plasmapheresis and rituximab. Rheumatology International, 28, 503 506. (Pubitemid 351629481)
16. Cambridge, G., Stohl, W., Leandro, M.J., Migone, T.S., Hilbert, D.M. Edwards, J.C. (2006a) Circulating levels of B lymphocyte stimulator in patients with rheumatoid arthritis following rituximab treatment: relationships with B cell depletion, circulating antibodies, and clinical relapse. Arthritis and Rheumatism, 54, 723 732.
17. Cambridge, G., Leandro, M.J., Teodorescu, M., Manson, J., Rahman, A., Isenberg, D.A. Edwards, J.C. (2006b) B cell depletion therapy in systemic lupus erythematosus: effect on autoantibody and antimicrobial antibody profiles. Arthritis and Rheumatism, 54, 3612 3622. (Pubitemid 44737173)
18. Cartron, G., Dacheux, L., Salles, G., Solal-Celigny, P., Bardos, P., Colombat, P. Watier, H. (2002) Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcgammaRIIIa gene. Blood, 99, 754 758. (Pubitemid 34525533)
19. Chung, L., Genovese, M.C. Fiorentino, D.F. (2007) A pilot trial of rituximab in the treatment of patients with dermatomyositis. Archives of Dermatology, 143, 763 767. (Pubitemid 46955736)
20. Cohen, S.B., Emery, P., Greenwald, M.W., Dougados, M., Furie, R.A., Genovese, M.C., Keystone, E.C., Loveless, J.E., Burmester, G.R., Cravets, M.W., Hessey, E.W., Shaw, T. Totoritis, M.C. (2006) Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks. Arthritis and Rheumatism, 54, 2793 2806. (Pubitemid 44497758)
21. Crawford, M.P., Yan, S.X., Ortega, S.B., Mehta, R.S., Hewitt, R.E., Price, D.A., Stastny, P., Douek, D.C., Koup, R.A., Racke, M.K. Karandikar, N.J. (2004) High prevalence of autoreactive, neuroantigen-specific CD8+ T cells in multiple sclerosis revealed by novel flow cytometric assay. Blood, 103, 4222 4231. (Pubitemid 38685367)
22. Crespo, M., Pascual, M., Tolkoff-Rubin, N., Mauiyyedi, S., Collins, A.B., Fitzpatrick, D., Farrell, M.L., Williams, W.W., Delmonico, F.L., Cosimi, A.B., Colvin, R.B. Saidman, S.L. (2001) Acute humoral rejection in renal allograft recipients: I. Incidence, serology and clinical characteristics. Transplantation, 71, 652 658. (Pubitemid 32268068)
23. Cross, A.H., Stark, J.L., Lauber, J., Ramsbottom, M.J. Lyons, J.A. (2006) Rituximab reduces B cells and T cells in cerebrospinal fluid of multiple sclerosis patients. Journal of Neuroimmunology, 180, 63 70. (Pubitemid 44767709)
24. Dass, S., Bowman, S.J., Vital, E.M., Ikeda, K., Pease, C.T., Hamburger, J., Richards, A., Rauz, S. Emery, P. (2008) Reduction of fatigue in Sjogren syndrome with rituximab: results of a randomised, double-blind, placebo-controlled pilot study. Annals of the Rheumatic Diseases, 67, 1541 1544.
25. Devauchelle-Pensec, V., Pennec, Y., Morvan, J., Pers, J.O., Daridon, C., Jousse-Joulin, S., Roudaut, A., Jamin, C., Renaudineau, Y., Roue, I.Q., Cochener, B., Youinou, P. Saraux, A. (2007) Improvement of Sjogren's syndrome after two infusions of rituximab (anti-CD20). Arthritis and Rheumatism, 57, 310 317. (Pubitemid 47164095)
26. Edwards, J.C. Cambridge, G. (2001) Sustained improvement in rheumatoid arthritis following a protocol designed to deplete B lymphocytes. Rheumatology (Oxford), 40, 205 211.
27. Edwards, J.C., Szczepanski, L., Szechinski, J., Filipowicz-Sosnowska, A., Emery, P., Close, D.R., Stevens, R.M. Shaw, T. (2004) Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis. The New England Journal of Medicine, 350, 2572 2581. (Pubitemid 38758544)
28. Egawa, H., Ohmori, K., Haga, H., Tsuji, H., Yurugi, K., Miyagawa-Hayashino, A., Oike, F., Fukuda, A., Yoshizawa, J., Takada, Y., Tanaka, K., Maekawa, T., Ozawa, K. Uemoto, S. (2007) B-cell surface marker analysis for improvement of rituximab prophylaxis in ABO-incompatible adult living donor liver transplantation. Liver Transplantation, 13, 579 588. (Pubitemid 46605862)
29. El Fassi, D., Nielsen, C.H., Hasselbalch, H.C. Hegedus, L. (2006) Treatment-resistant severe, active Graves' ophthalmopathy successfully treated with B lymphocyte depletion. Thyroid, 16, 709 710. (Pubitemid 44246272)
30. El Fassi, D., Nielsen, C.H., Bonnema, S.J., Hasselbalch, H.C. Hegedus, L. (2007) B lymphocyte depletion with the monoclonal antibody rituximab in Graves' disease: a controlled pilot study. The Journal of Clinical Endocrinology and Metabolism, 92, 1769 1772. (Pubitemid 46997186)
31. El Fassi, D., Banga, J.P., Gilbert, J.A., Padoa, C., Hegedus, L. Nielsen, C.H. (2009) Treatment of Graves' disease with rituximab specifically reduces the production of thyroid stimulating autoantibodies. Clinical Immunology, 130, 252 258.
32. Emery, P., Fleischmann, R., Filipowicz-Sosnowska, A., Schechtman, J., Szczepanski, L., Kavanaugh, A., Racewicz, A.J., van Vollenhoven, R.F., Li, N.F., Agarwal, S., Hessey, E.W. Shaw, T.M. (2006) The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment: results of a phase IIB randomized, double-blind, placebo-controlled, dose-ranging trial. Arthritis and Rheumatism, 54, 1390 1400.
33. Eming, R., Nagel, A., Wolff-Franke, S., Podstawa, E., Debus, D. Hertl, M. (2008) Rituximab exerts a dual effect in pemphigus vulgaris. The Journal of Investigative Dermatology, 128, 2850 2858.
34. Fernandez-Fresnedo, G., Ramos, M.A., Gonzalez-Pardo, M.C., de Francisco, A.L., Lopez-Hoyos, M. Arias, M. (2000) B lymphopenia in uremia is related to an accelerated in vitro apoptosis and dysregulation of Bcl-2. Nephrology, Dialysis, Transplantation, 15, 502 510. (Pubitemid 30160657)
35. Ferraro, A.J., Drayson, M.T., Savage, C.O. MacLennan, I.C. (2008) Levels of autoantibodies, unlike antibodies to all extrinsic antigen groups, fall following B cell depletion with Rituximab. European Journal of Immunology, 38, 292 298.
36. Fervenza, F.C., Cosio, F.G., Erickson, S.B., Specks, U., Herzenberg, A.M., Dillon, J.J., Leung, N., Cohen, I.M., Wochos, D.N., Bergstralh, E., Hladunewich, M. Cattran, D.C. (2008) Rituximab treatment of idiopathic membranous nephropathy. Kidney International, 73, 117 125. (Pubitemid 350273646)
37. Gajra, A., Vajpayee, N. Grethlein, S.J. (2004) Response of myasthenia gravis to rituximab in a patient with non-Hodgkin lymphoma. American Journal of Hematology, 77, 196 197. (Pubitemid 39281869)
38. Garrett, Jr., H.E., Duvall-Seaman, D., Helsley, B. Groshart, K. (2005) Treatment of vascular rejection with rituximab in cardiac transplantation. The Journal of Heart and Lung Transplantation, 24, 1337 1342. (Pubitemid 41247819)
39. Genain, C.P., Cannella, B., Hauser, S.L. Raine, C.S. (1999) Identification of autoantibodies associated with myelin damage in multiple sclerosis. Nature Medicine, 5, 170 175. (Pubitemid 29068523)
40. Genberg, H., Hansson, A., Wernerson, A., Wennberg, L. Tyden, G. (2006) Pharmacodynamics of rituximab in kidney allotransplantation. American Journal of Transplantation, 6, 2418 2428. (Pubitemid 44359429)
41. Genberg, H., Kumlien, G., Wennberg, L., Berg, U. Tyden, G. (2008) ABO-incompatible kidney transplantation using antigen-specific immunoadsorption and rituximab: a 3-year follow-up. Transplantation, 85, 1745 1754.
42. Ginaldi, L., De, M.M., Matutes, E., Farahat, N., Morilla, R. Catovsky, D. (1998) Levels of expression of CD19 and CD20 in chronic B cell leukaemias. Journal of Clinical Pathology, 51, 364 369. (Pubitemid 28289122)
43. Glotz, D., Antoine, C., Julia, P., Suberbielle-Boissel, C., Boudjeltia, S., Fraoui, R., Hacen, C., Duboust, A. Bariety, J. (2002) Desensitization and subsequent kidney transplantation of patients using intravenous immunoglobulins (IVIg). American Journal of Transplantation, 2, 758 760. (Pubitemid 36342618)
44. Gorson, K.C., Natarajan, N., Ropper, A.H. Weinstein, R. (2007) Rituximab treatment in patients with IVIg-dependent immune polyneuropathy: a prospective pilot trial. Muscle and Nerve, 35, 66 69. (Pubitemid 46052650)
45. Gunnarsson, I., Sundelin, B., Jonsdottir, T., Jacobson, S.H., Henriksson, E.W. van Vollenhoven, R.F. (2007) Histopathologic and clinical outcome of rituximab treatment in patients with cyclophosphamide-resistant proliferative lupus nephritis. Arthritis and Rheumatism, 56, 1263 1272. (Pubitemid 46608651)
46. Hammond, E.H., Yowell, R.L., Nunoda, S., Menlove, R.L., Renlund, D.G., Bristow, M.R., Gay Jr., W.A., Jones, K.W. O'Connell, J.B. (1989) Vascular (humoral) rejection in heart transplantation: pathologic observations and clinical implications. The Journal of Heart Transplantation, 8, 430 443. (Pubitemid 20044096)
47. Harjunpaa, A., Junnikkala, S. Meri, S. (2000) Rituximab (anti-CD20) therapy of B-cell lymphomas: direct complement killing is superior to cellular effector mechanisms. Scandinavian Journal of Immunology, 51, 634 641. (Pubitemid 30353375)
48. Hauser, S.L., Waubant, E., Arnold, D.L., Vollmer, T., Antel, J., Fox, R.J., Bar-Or, A., Panzara, M., Sarkar, N., Agarwal, S., Langer-Gould, A. Smith, C.H. (2008) B-cell depletion with rituximab in relapsing-remitting multiple sclerosis. The New England Journal of Medicine, 358, 676 688. (Pubitemid 351240747)
49. Hippen, B.E., DeMattos, A., Cook, W.J., Kew, C.E. Gaston, R.S. (2005) Association of CD20+ infiltrates with poorer clinical outcomes in acute cellular rejection of renal allografts. American Journal of Transplantation, 5, 2248 2252. (Pubitemid 41648473)
50. Illa, I., az-Manera, J., Rojas-Garcia, R., Pradas, J., Rey, A., Blesa, R., Juarez, C. Gallardo, E. (2008) Sustained response to Rituximab in anti-AChR and anti-MuSK positive Myasthenia Gravis patients. Journal of Neuroimmunology, 201 202, 90 94.
51. Ishida, H., Tanabe, K., Ishizuka, T., Furusawa, M., Miyamoto, N., Ishikawa, N., Shirakawa, H., Shimmura, H., Ishii, D., Nozaki, D., Setoguchi, K. Toma, H. (2006) Differences in humoral immunity between a non-rejection group and a rejection group after ABO-incompatible renal transplantation. Transplantation, 81, 665 671.
52. Jacob, A., Weinshenker, B.G., Violich, I., McLinskey, N., Krupp, L., Fox, R.J., Wingerchuk, D.M., Boggild, M., Constantinescu, C.S., Miller, A., De, A.T., Matiello, M. Cree, B.A. (2008) Treatment of neuromyelitis optica with rituximab: retrospective analysis of 25 patients. Archives of Neurology, 65, 1443 1448.
53. Jillella, A.P., Dainer, P.M., Kallab, A.M. Ustun, C. (2002) Treatment of a patient with end-stage renal disease with Rituximab: pharmacokinetic evaluation suggests Rituximab is not eliminated by hemodialysis. American Journal of Hematology, 71, 219 222. (Pubitemid 35253340)
54. Joly, P., Mouquet, H., Roujeau, J.C., D'Incan, M., Gilbert, D., Jacquot, S., Gougeon, M.L., Bedane, C., Muller, R., Dreno, B., Doutre, M.S., Delaporte, E., Pauwels, C., Franck, N., Caux, F., Picard, C., Tancrede-Bohin, E., Bernard, P., Tron, F., Hertl, M. Musette, P. (2007) A single cycle of rituximab for the treatment of severe pemphigus. The New England Journal of Medicine, 357, 545 552. (Pubitemid 47236279)
55. Jordan, S.C., Tyan, D., Stablein, D., McIntosh, M., Rose, S., Vo, A., Toyoda, M., Davis, C., Shapiro, R., Adey, D., Milliner, D., Graff, R., Steiner, R., Ciancio, G., Sahney, S. Light, J. (2004) Evaluation of intravenous immunoglobulin as an agent to lower allosensitization and improve transplantation in highly sensitized adult patients with end-stage renal disease: report of the NIH IG02 trial. Journal of the American Society of Nephrology, 15, 3256 3262. (Pubitemid 39578859)
56. Kaczmarek, I., Deutsch, M.A., Sadoni, S., Brenner, P., Schmauss, D., Daebritz, S.H., Weiss, M., Meiser, B.M. Reichart, B. (2007) Successful management of antibody-mediated cardiac allograft rejection with combined immunoadsorption and anti-CD20 monoclonal antibody treatment: case report and literature review. The Journal of Heart and Lung Transplantation, 26, 511 515. (Pubitemid 46602000)
57. Kaposztas, Z., Podder, H., Mauiyyedi, S., Illoh, O., Kerman, R., Reyes, M., Pollard, V. Kahan, B.D. (2009) Impact of rituximab therapy for treatment of acute humoral rejection Abstract). Clinical Transplantation, 23, 63 73.
58. Keogh, K.A., Wylam, M.E., Stone, J.H. Specks, U. (2005) Induction of remission by B lymphocyte depletion in eleven patients with refractory antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis and Rheumatism, 52, 262 268. (Pubitemid 40129256)
59. Keogh, K.A., Ytterberg, S.R., Fervenza, F.C., Carlson, K.A., Schroeder, D.R. Specks, U. (2006) Rituximab for refractory Wegener's granulomatosis: report of a prospective, open-label pilot trial. American Journal of Respiratory and Critical Care Medicine, 173, 180 187. (Pubitemid 43187890)
60. Kerjaschki, D. Neale, T.J. (1996) Molecular mechanisms of glomerular injury in rat experimental membranous nephropathy (Heymann nephritis). Journal of the American Society of Nephrology, 7, 2518 2526. (Pubitemid 27469557)
61. Keystone, E., Fleischmann, R., Emery, P., Furst, D.E., van, V.R., Bathon, J., Dougados, M., Baldassare, A., Ferraccioli, G., Chubick, A., Udell, J., Cravets, M.W., Agarwal, S., Cooper, S. Magrini, F. (2007) Safety and efficacy of additional courses of rituximab in patients with active rheumatoid arthritis: an open-label extension analysis. Arthritis and Rheumatism, 56, 3896 3908. (Pubitemid 350262316)
62. Kissel, J.T., Mendell, J.R. Rammohan, K.W. (1986) Microvascular deposition of complement membrane attack complex in dermatomyositis. The New England Journal of Medicine, 314, 329 334. (Pubitemid 16166259)
63. Koukoulaki, M., Abeygunasekara, S.C., Smith, K.G. Jayne, D.R. (2005) Remission of refractory hepatitis C-negative cryoglobulinaemic vasculitis after rituximab and infliximab. Nephrology, Dialysis, Transplantation, 20, 213 216. (Pubitemid 40207630)
64. Lake-Bakaar, G., Dustin, L., McKeating, J., Newton, K., Freeman, V. Frost, S.D. (2007) Hepatitis C virus and alanine aminotransferase kinetics following B-lymphocyte depletion with rituximab: evidence for a significant role of humoral immunity in the control of viremia in chronic HCV liver disease. Blood, 109, 845 846. (Pubitemid 46105993)
65. Leandro, M.J., Edwards, J.C. Cambridge, G. (2002a) Clinical outcome in 22 patients with rheumatoid arthritis treated with B lymphocyte depletion. Annals of the Rheumatic Diseases, 61, 883 888.
66. Leandro, M.J., Edwards, J.C., Cambridge, G., Ehrenstein, M.R. Isenberg, D.A. (2002b) An open study of B lymphocyte depletion in systemic lupus erythematosus. Arthritis and Rheumatism, 46, 2673 2677. (Pubitemid 36118931)
67. Leandro, M.J., Cambridge, G., Edwards, J.C., Ehrenstein, M.R. Isenberg, D.A. (2005) B-cell depletion in the treatment of patients with systemic lupus erythematosus: a longitudinal analysis of 24 patients. Rheumatology (Oxford), 44, 1542 1545. (Pubitemid 41742472)
68. Leandro, M.J., Cambridge, G., Ehrenstein, M.R. Edwards, J.C. (2006) Reconstitution of peripheral blood B cells after depletion with rituximab in patients with rheumatoid arthritis. Arthritis and Rheumatism, 54, 613 620. (Pubitemid 43228639)
69. Levine, T.D. (2005) Rituximab in the treatment of dermatomyositis: an open-label pilot study. Arthritis and Rheumatism, 52, 601 607. (Pubitemid 40216325)
70. Levine, T.D. Pestronk, A. (1999) IgM antibody-related polyneuropathies: B-cell depletion chemotherapy using Rituximab. Neurology, 52, 1701 1704. (Pubitemid 29220654)
71. Looney, R.J., Anolik, J.H., Campbell, D., Felgar, R.E., Young, F., Arend, L.J., Sloand, J.A., Rosenblatt, J. Sanz, I. (2004) B cell depletion as a novel treatment for systemic lupus erythematosus: a phase I/II dose-escalation trial of rituximab. Arthritis and Rheumatism, 50, 2580 2589. (Pubitemid 39062719)
72. Lovric, S., Erdbruegger, U., Kumpers, P., Woywodt, A., Koenecke, C., Wedemeyer, H., Haller, H. Haubitz, M. (2009) Rituximab as rescue therapy in anti-neutrophil cytoplasmic antibody-associated vasculitis: a single-centre experience with 15 patients. Nephrology, Dialysis, Transplantation, 24, 179 185.
73. Lucchinetti, C.F., Mandler, R.N., McGavern, D., Bruck, W., Gleich, G., Ransohoff, R.M., Trebst, C., Weinshenker, B., Wingerchuk, D., Parisi, J.E. Lassmann, H. (2002) A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica. Brain : A Journal of Neurology, 125, 1450 1461. (Pubitemid 34755161)
74. Maloney, D.G., Liles, T.M., Czerwinski, D.K., Waldichuk, C., Rosenberg, J., Grillo-Lopez, A. Levy, R. (1994) Phase I clinical trial using escalating single-dose infusion of chimeric anti-CD20 monoclonal antibody (IDEC-C2B8) in patients with recurrent B-cell lymphoma. Blood, 84, 2457 2466. (Pubitemid 24317376)
75. Maloney, D.G., Grillo-Lopez, A.J., White, C.A., Bodkin, D., Schilder, R.J., Neidhart, J.A., Janakiraman, N., Foon, K.A., Liles, T.M., Dallaire, B.K., Wey, K., Royston, I., Davis, T. Levy, R. (1997) IDEC-C2B8 (Rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin's lymphoma. Blood, 90, 2188 2195. (Pubitemid 27392702)
76. Mauiyyedi, S. Colvin, R.B. (2002) Humoral rejection in kidney transplantation: new concepts in diagnosis and treatment. Current Opinion in Nephrology and Hypertension, 11, 609 618. (Pubitemid 35440842)
77. McLaughlin, P., Grillo-Lopez, A.J., Link, B.K., Levy, R., Czuczman, M.S., Williams, M.E., Heyman, M.R., ce-Bruckler, I., White, C.A., Cabanillas, F., Jain, V., Ho, A.D., Lister, J., Wey, K., Shen, D. Dallaire, B.K. (1998) Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program. Journal of Clinical Oncology, 16, 2825 2833. (Pubitemid 28363048)
78. Meijer, J.M., Pijpe, J., Vissink, A., Kallenberg, C.G. Bootsma, H. (2009) Treatment of primary Sjogren syndrome with rituximab: extended follow-up, safety and efficacy of retreatment. Annals of the Rheumatic Diseases, 68, 284 285.
79. Merrill, J.T., Neuwelt, C.M., Wallace, D.J., Shanahan, J.C., Latinis, K.M., Oates, J.C., Utset, T.O., Gordon, C., Isenberg, D.A., Hsieh, H.J., Zhang, D. Brunetta, P.G. (2008) Efficacy and safety of rituximab in patients with moderately to severely active systemic lupus erythematosus (SLE): results from the randomised, double-blind phase II/III study EXPLORER Abstract). Arthritis and Rheumatism, 58S, oral presentation L12.
80. Mok, C.C., Ho, L.Y. To, C.H. (2007) Rituximab for refractory polymyositis: an open-label prospective study. The Journal of Rheumatology, 34, 1864 1868. (Pubitemid 350067647)
81. Molloy, E.S. Calabrese, L.H. (2008) Progressive multifocal leukoencephalopathy in patients with rheumatic diseases: are patients with systemic lupus erythematosus at particular risk? Autoimmunity Reviews, 8, 144 146.
82. Montgomery, R.A., Zachary, A.A., Racusen, L.C., Leffell, M.S., King, K.E., Burdick, J., Maley, W.R. Ratner, L.E. (2000) Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplanted into cross-match-positive recipients. Transplantation, 70, 887 895. (Pubitemid 30746025)
83. Mouquet, H., Musette, P., Gougeon, M.L., Jacquot, S., Lemercier, B., Lim, A., Gilbert, D., Dutot, I., Roujeau, J.C., D'Incan, M., Bedane, C., Tron, F. Joly, P. (2008) B-cell depletion immunotherapy in pemphigus: effects on cellular and humoral immune responses. The Journal of Investigative Dermatology, 128, 2859 2869.
84. Mulley, W.R., Hudson, F.J., Tait, B.D., Skene, A.M., Dowling, J.P., Kerr, P.G. Kanellis, J. (2009) A single low-fixed dose of rituximab to salvage renal transplants from refractory antibody-mediated rejection. Transplantation, 87, 286 289.
85. Ng, K.P., Cambridge, G., Leandro, M.J., Edwards, J.C., Ehrenstein, M. Isenberg, D.A. (2007) B cell depletion therapy in systemic lupus erythematosus: long-term follow-up and predictors of response. Annals of the Rheumatic Diseases, 66, 1259 1262. (Pubitemid 47309748)
86. Nived, O., Bengtsson, A.A., Jonsen, A. Sturfelt, G. (2008) Progressive multifocal leukoencephalopathy - the importance of early diagnosis illustrated in four cases. Lupus, 17, 1036 1041.
87. Noss, E.H., Hausner-Sypek, D.L. Weinblatt, M.E. (2006) Rituximab as therapy for refractory polymyositis and dermatomyositis. The Journal of Rheumatology, 33, 1021 1026.
88. Pestronk, A., Florence, J., Miller, T., Choksi, R., Al-Lozi, M.T. Levine, T.D. (2003) Treatment of IgM antibody associated polyneuropathies using rituximab. Journal of Neurology, Neurosurgery, and Psychiatry, 74, 485 489. (Pubitemid 36379372)
89. Petereit, H. Rubbert-Roth, A. (2009) Rituximab levels in cerebrospinal fluid of patients with neurological autoimmune disorders. Multiple Sclerosis, 15, 189 192.
90. Pijpe, J., van Imhoff, G.W., Spijkervet, F.K., Roodenburg, J.L., Wolbink, G.J., Mansour, K., Vissink, A., Kallenberg, C.G. Bootsma, H. (2005) Rituximab treatment in patients with primary Sjogren's syndrome: an open-label phase II study. Arthritis and Rheumatism, 52, 2740 2750. (Pubitemid 41369102)
91. Popa, C., Leandro, M.J., Cambridge, G. Edwards, J.C. (2007) Repeated B lymphocyte depletion with rituximab in rheumatoid arthritis over 7 yrs. Rheumatology (Oxford), 46, 626 630. (Pubitemid 46523308)
92. Press, O.W., Appelbaum, F., Ledbetter, J.A., Martin, P.J., Zarling, J., Kidd, P. Thomas, E.D. (1987) Monoclonal antibody 1F5 (anti-CD20) serotherapy of human B cell lymphomas. Blood, 69, 584 591. (Pubitemid 17022032)
93. Press, O.W., Howell-Clark, J., Anderson, S. Bernstein, I. (1994) Retention of B-cell-specific monoclonal antibodies by human lymphoma cells. Blood, 83, 1390 1397. (Pubitemid 24062863)
94. Qin, Y., Duquette, P., Zhang, Y., Talbot, P., Poole, R. Antel, J. (1998) Clonal expansion and somatic hypermutation of V(H) genes of B cells from cerebrospinal fluid in multiple sclerosis. The Journal of Clinical Investigation, 102, 1045 1050. (Pubitemid 28419250)
95. Quartuccio, L., Soardo, G., Romano, G., Zaja, F., Scott, C.A., De, M.G., Fabris, M., Ferraccioli, G. De, V.S. (2006) Rituximab treatment for glomerulonephritis in HCV-associated mixed cryoglobulinaemia: efficacy and safety in the absence of steroids. Rheumatology (Oxford), 45, 842 846. (Pubitemid 43985372)
96. Quartuccio, L., Salvin, S., Fabris, M., Sacco, S. De, V.S. (2008) Disappearance of bone marrow B cell clonal expansion in patients with type II hepatitis C virus-related cryoglobulinemic glomerulonephritis after clinical efficient rituximab therapy. Annals of the Rheumatic Diseases, 67, 1494 1495.
97. Reff, M.E., Carner, K., Chambers, K.S., Chinn, P.C., Leonard, J.E., Raab, R., Newman, R.A., Hanna, N. Anderson, D.R. (1994) Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20. Blood, 83, 435 445. (Pubitemid 24030569)
98. Renaud, S., Gregor, M., Fuhr, P., Lorenz, D., Deuschl, G., Gratwohl, A. Steck, A.J. (2003) Rituximab in the treatment of polyneuropathy associated with anti-MAG antibodies. Muscle and Nerve, 27, 611 615. (Pubitemid 36523521)
99. Renaud, S., Fuhr, P., Gregor, M., Schweikert, K., Lorenz, D., Daniels, C., Deuschl, G., Gratwohl, A. Steck, A.J. (2006) High-dose rituximab and anti-MAG-associated polyneuropathy. Neurology, 66, 742 744. (Pubitemid 43739834)
100. Reynolds, J., Toescu, V., Yee, C., Prabu, A., Situnayake, D. Gordon, C. (2009) Effects of rituximab on resistant SLE disease including lung involvement. Lupus, 18, 67 73.
101. Risselada, A.P. Kallenberg, C.G. (2006) Therapy-resistent lupus skin disease successfully treated with rituximab. Rheumatology (Oxford), 45, 915 916. (Pubitemid 43985387)
102. Roccatello, D., Baldovino, S., Rossi, D., Mansouri, M., Naretto, C., Gennaro, M., Cavallo, R., Alpa, M., Costanzo, P., Giachino, O., Mazzucco, G. Sena, L.M. (2004) Long-term effects of anti-CD20 monoclonal antibody treatment of cryoglobulinaemic glomerulonephritis. Nephrology, Dialysis, Transplantation, 19, 3054 3061. (Pubitemid 40057628)
103. Roccatello, D., Baldovino, S., Alpa, M., Rossi, D., Napoli, F., Naretto, C., Cavallo, R. Giachino, O. (2008) Effects of anti-CD20 monoclonal antibody as a rescue treatment for ANCA-associated idiopathic systemic vasculitis with or without overt renal involvement. Clinical and Experimental Dermatology, 26, S67 S71.
104. Ruggenenti, P., Chiurchiu, C., Brusegan, V., Abbate, M., Perna, A., Filippi, C. Remuzzi, G. (2003) Rituximab in idiopathic membranous nephropathy: a one-year prospective study. Journal of the American Society of Nephrology, 14, 1851 1857. (Pubitemid 36750480)
105. Rydberg, L. (2001) ABO-incompatibility in solid organ transplantation. Transfusion Medicine, 11, 325 342. (Pubitemid 32771925)
106. Saadoun, D., Resche-Rigon, M., Sene, D., Perard, L., Karras, A. Cacoub, P. (2008) Rituximab combined with Peg-interferon-ribavirin in refractory hepatitis C virus-associated cryoglobulinaemia vasculitis. Annals of the Rheumatic Diseases, 67, 1431 1436.
107. Saito, K., Nawata, M., Iwata, S., Tokunaga, M. Tanaka, Y. (2005) Extremely high titer of anti-human chimeric antibody following re-treatment with rituximab in a patient with active systemic lupus erythematosus. Rheumatology (Oxford), 44, 1462 1464. (Pubitemid 41631879)
108. Salant, D.J., Belok, S., Madaio, M.P. Couser, W.G. (1980) A new role for complement in experimental membranous nephropathy in rats. The Journal of Clinical Investigation, 66, 1339 1350. (Pubitemid 11205596)
109. Salvi, M., Vannucchi, G., Campi, I., Curro, N., Dazzi, D., Simonetta, S., Bonara, P., Rossi, S., Sina, C., Guastella, C., Ratiglia, R. Beck-Peccoz, P. (2007) Treatment of Graves' disease and associated ophthalmopathy with the anti-CD20 monoclonal antibody rituximab: an open study. European Journal of Endocrinology, 156, 33 40. (Pubitemid 46553901)
110. Sansonno, D., De, R.V., Lauletta, G., Tucci, F.A., Boiocchi, M. Dammacco, F. (2003) Monoclonal antibody treatment of mixed cryoglobulinemia resistant to interferon alpha with an anti-CD20. Blood, 101, 3818 3826. (Pubitemid 36857852)
111. Sarkar, K. Miller, F.W. (2004) Autoantibodies as predictive and diagnostic markers of idiopathic inflammatory myopathies. Autoimmunity, 37, 291 294. (Pubitemid 39172914)
112. Scheepstra, C., Bemelman, F.J., van der Loos, C., Rowshani, A.T., van Donselaar-Van der Pant, K.A., Idu, M.M., ten, B.I. Florquin, S. (2008) B cells in cluster or in a scattered pattern do not correlate with clinical outcome of renal allograft rejection. Transplantation, 86, 772 778.
113. Seror, R., Sordet, C., Guillevin, L., Hachulla, E., Masson, C., Ittah, M., Candon, S., Le, G.V., Aouba, A., Sibilia, J., Gottenberg, J.E. Mariette, X. (2007) Tolerance and efficacy of rituximab and changes in serum B cell biomarkers in patients with systemic complications of primary Sjogren's syndrome. Annals of the Rheumatic Diseases, 66, 351 357. (Pubitemid 46579637)
114. Sfikakis, P.P., Boletis, J.N., Lionaki, S., Vigklis, V., Fragiadaki, K.G., Iniotaki, A. Moutsopoulos, H.M. (2005) Remission of proliferative lupus nephritis following B cell depletion therapy is preceded by down-regulation of the T cell costimulatory molecule CD40 ligand: an open-label trial. Arthritis and Rheumatism, 52, 501 513. (Pubitemid 40216314)
115. Sfikakis, P.P., Souliotis, V.L., Fragiadaki, K.G., Moutsopoulos, H.M., Boletis, J.N. Theofilopoulos, A.N. (2007) Increased expression of the FoxP3 functional marker of regulatory T cells following B cell depletion with rituximab in patients with lupus nephritis. Clinical Immunology, 123, 66 73. (Pubitemid 46401511)
116. Shams'ili, S., de, B.J., Gratama, J.W., Hooijkaas, H., van den Bent M., van., 't Veer, M. Sillevis, S.P. (2006) An uncontrolled trial of rituximab for antibody associated paraneoplastic neurological syndromes. Journal of Neurology, 253, 16 20. (Pubitemid 43157382)
117. Shan, D., Ledbetter, J.A. Press, O.W. (1998) Apoptosis of malignant human B cells by ligation of CD20 with monoclonal antibodies. Blood, 91, 1644 1652. (Pubitemid 28110329)
118. Siden, A. (1979) Isoelectric focusing and crossed immunoelectrofocusing of CSF immunoglobulins in MS. Journal of Neurology, 221, 39 51. (Pubitemid 9245037)
119. Smith, K.G., Jones, R.B., Burns, S.M. Jayne, D.R. (2006) Long-term comparison of rituximab treatment for refractory systemic lupus erythematosus and vasculitis: remission, relapse, and re-treatment. Arthritis and Rheumatism, 54, 2970 2982. (Pubitemid 44497778)
120. Sonnenday, C.J., Warren, D.S., Cooper, M., Samaniego, M., Haas, M., King, K.E., Shirey, R.S., Simpkins, C.E. Montgomery, R.A. (2004) Plasmapheresis, CMV hyperimmune globulin, and anti-CD20 allow ABO-incompatible renal transplantation without splenectomy. American Journal of Transplantation, 4, 1315 1322. (Pubitemid 39013579)
121. Squifflet, J.P., De Meyer, M., Malaise, J., Latinne, D., Pirson, Y. Alexandre, G.P. (2004) Lessons learned from ABO-incompatible living donor kidney transplantation: 20 years later. Experimental and Clinical Transplantation, 2, 208 213.
122. Steinmetz, O.M., Lange-Husken, F., Turner, J.E., Vernauer, A., Helmchen, U., Stahl, R.A., Thaiss, F. Panzer, U. (2007) Rituximab removes intrarenal B cell clusters in patients with renal vascular allograft rejection. Transplantation, 84, 842 850. (Pubitemid 351338944)
123. Tak, P.P., Cohen, S., Emery, P., Saadeh, C.K., De Vita, S., Donohue, J.P., McDabe, D.P., Shaw, T. Magrini, F. (2006) Baseline autoantibody status (RF, anti-CCP) and clinical response following the first treatment course with rituximab Abstract). Arthritis and Rheumatism, 54 (Suppl Presentation 833.
124. Tanabe, K., Ishida, H., Shimizu, T., Omoto, K., Shirakawa, H. Tokumoto, T. (2009) Evaluation of two different preconditioning regimens for ABO-incompatible living kidney donor transplantation. A comparison of splenectomy vs. rituximab-treated non-splenectomy preconditioning regimens. Contributions to Nephrology, 162, 61 74.
125. Todd, D.J. Helfgott, S.M. (2007) Serum sickness following treatment with rituximab. The Journal of Rheumatology, 34, 430 433. (Pubitemid 46255766)
126. Tokunaga, M., Fujii, K., Saito, K., Nakayamada, S., Tsujimura, S., Nawata, M. Tanaka, Y. (2005) Down-regulation of CD40 and CD80 on B cells in patients with life-threatening systemic lupus erythematosus after successful treatment with rituximab. Rheumatology (Oxford), 44, 176 182. (Pubitemid 40277398)
127. Tokunaga, M., Saito, K., Kawabata, D., Imura, Y., Fujii, T., Nakayamada, S., Tsujimura, S., Nawata, M., Iwata, S., Azuma, T., Mimori, T. Tanaka, Y. (2007) Efficacy of rituximab (anti-CD20) for refractory systemic lupus erythematosus involving the central nervous system. Annals of the Rheumatic Diseases, 66, 470 475. (Pubitemid 46580466)
128. Touma, Z., Arayssi, T., Kibbi, L. Masri, A.F. (2008) Successful treatment of cardiac involvement in dermatomyositis with rituximab. Joint, Bone, Spine, 75, 334 337. (Pubitemid 351609418)
129. Tyden, G., Donauer, J., Wadstrom, J., Kumlien, G., Wilpert, J., Nilsson, T., Genberg, H., Pisarski, P. Tufveson, G. (2007) Implementation of a protocol for ABO-incompatible kidney transplantation - a three-center experience with 60 consecutive transplantations. Transplantation, 83, 1153 1155. (Pubitemid 46743673)
130. Usuda, M., Fujimori, K., Koyamada, N., Fukumori, T., Sekiguchi, S., Kawagishi, N., Akamatsu, Y., Enomoto, Y., Satoh, K., Satoh, A., Ishida, K., Moriya, T. Satomi, S. (2005) Successful use of anti-CD20 monoclonal antibody (rituximab) for ABO-incompatible living-related liver transplantation. Transplantation, 79, 12 16. (Pubitemid 40139994)
131. Usui, M., Isaji, S., Mizuno, S., Sakurai, H. Uemoto, S. (2007) Experiences and problems pre-operative anti-CD20 monoclonal antibody infusion therapy with splenectomy and plasma exchange for ABO-incompatible living-donor liver transplantation. Clinical Transplantation, 21, 24 31. (Pubitemid 46189584)
132. Vallerskog, T., Gunnarsson, I., Widhe, M., Risselada, A., Klareskog, L., van Vollenhoven, R., Malmstrom, V. Trollmo, C. (2007) Treatment with rituximab affects both the cellular and the humoral arm of the immune system in patients with SLE. Clinical Immunology, 122, 62 74. (Pubitemid 46026695)
133. Vieira, C.A., Agarwal, A., Book, B.K., Sidner, R.A., Bearden, C.M., Gebel, H.M., Roggero, A.L., Fineberg, N.S., Taber, T., Kraus, M.A. Pescovitz, M.D. (2004) Rituximab for reduction of anti-HLA antibodies in patients awaiting renal transplantation: 1. Safety, pharmacodynamics, and pharmacokinetics. Transplantation, 77, 542 548. (Pubitemid 38282809)
134. Viglietta, V., Baecher-Allan, C., Weiner, H.L. Hafler, D.A. (2004) Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis. The Journal of Experimental Medicine, 199, 971 979. (Pubitemid 38481088)
135. Vigna-Perez, M., Hernandez-Castro, B., Paredes-Saharopulos, O., Portales-Perez, D., Baranda, L., bud-Mendoza, C. Gonzalez-Amaro, R. (2006) Clinical and immunological effects of Rituximab in patients with lupus nephritis refractory to conventional therapy: a pilot study. Arthritis Research & Therapy, 8, R83.
136. Visentini, M., Granata, M., Veneziano, M.L., Borghese, F., Carlesimo, M., Pimpinelli, F., Fiorilli, M. Casato, M. (2007) Efficacy of low-dose rituximab for mixed cryoglobulinemia. Clinical Immunology, 125, 30 33. (Pubitemid 47374540)
137. Vo, A.A., Lukovsky, M., Toyoda, M., Wang, J., Reinsmoen, N.L., Lai, C.H., Peng, A., Villicana, R. Jordan, S.C. (2008) Rituximab and intravenous immune globulin for desensitization during renal transplantation. The New England Journal of Medicine, 359, 242 251. (Pubitemid 352008439)
138. Watson, R., Kozlowski, T., Nickeleit, V., Woosley, J.T., Schmitz, J.L., Zacks, S.L., Fair, J.H., Gerber, D.A. Andreoni, K.A. (2006) Isolated donor specific alloantibody-mediated rejection after ABO compatible liver transplantation. American Journal of Transplantation, 6, 3022 3029. (Pubitemid 44777934)
139. Weide, R., Heymanns, J., Pandorf, A. Koppler, H. (2003) Successful long-term treatment of systemic lupus erythematosus with rituximab maintenance therapy. Lupus, 12, 779 782. (Pubitemid 37295814)
140. Zaja, F., De, V.S., Mazzaro, C., Sacco, S., Damiani, D., De, M.G., Michelutti, A., Baccarani, M., Fanin, R. Ferraccioli, G. (2003) Efficacy and safety of rituximab in type II mixed cryoglobulinemia. Blood, 101, 3827 3834. (Pubitemid 36857853)
141. Zapata, L.F., Agudelo, L.M., Paulo, J.D. Pineda, R. (2007) Sjogren keratoconjunctivitis sicca treated with rituximab. Cornea, 26, 886 887. (Pubitemid 47220569)